NCT06099418 2024-09-20Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.Nykode Therapeutics ASAPhase 2 Withdrawn
NCT04405349 2023-12-15Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical CancerNykode Therapeutics ASAPhase 2 Completed52 enrolled